CID 118893637

Segigratinib

Structural Information

Molecular Formula
C27H28Cl2N6O3
SMILES
CC1(CN(CCN1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3C=CC(=N4)C5=C(C(=CC(=C5Cl)OC)OC)Cl)C
InChI
InChI=1S/C27H28Cl2N6O3/c1-27(2)14-35(12-11-30-27)16-7-5-15(6-8-16)26(36)32-25-17-9-10-18(31-24(17)33-34-25)21-22(28)19(37-3)13-20(38-4)23(21)29/h5-10,13,30H,11-12,14H2,1-4H3,(H2,31,32,33,34,36)
InChIKey
QNXOYMFBIACDSL-UHFFFAOYSA-N
Compound name
N-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-4-(3,3-dimethylpiperazin-1-yl)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

3
Patents

554.16 Da
Monoisotopic Mass

4.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 555.16728 230.2
[M+Na]+ 577.14922 246.4
[M+NH4]+ 572.19382 236.0
[M+K]+ 593.12316 238.0
[M-H]- 553.15272 235.2
[M+Na-2H]- 575.13467 238.1
[M]+ 554.15945 234.6
[M]- 554.16055 234.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe